Drawing for DETERMACNI

USPTO serial 99240733

DETERMACNI

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
VALLILLO, MELISSA C
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with DETERMACNI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher D Olszyk, Jr.

Christopher D Olszyk, Jr. Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents for clinical or medical laboratory research use; diagnostic reagents for scientific or research use; reagents for scientific or medical research useACTIVE—
005Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical useACTIVE—
010Biopsy tests and devices, namely, medical instruments for use in performing blood-based testing and medical diagnostic apparatus for testing changes in biomarkers; cancer screening tests and devices, namely, medical devices for post-cancer treatment reoccurrence monitoring; medical diagnostic apparatus for testing patients' post-cancer treatment biomarkersACTIVE—
044Medical services, namely, providing blood testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence; Providing blood reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrenceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2026EX1GSOU EXTENSION 1 GRANTED—
Aug 3, 2026EXT1SOU EXTENSION 1 FILED—
Aug 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 6, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 6, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 6, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 6, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 6, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 6, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 6, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 6, 2025DOCKASSIGNED TO EXAMINER—
Oct 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 18, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance